Picture of Devyser Diagnostics AB logo

DVYSR — Devyser Diagnostics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Brief: Devyser Q2 Sales At SEK 60.2 Mln, Weaker Than Expected

BRIEF-Devyser Q2 Sales At SEK 60.2 Mln, Weaker Than Expected

- Devyser Diagnostics AB DVYSR.ST:

  • SALES IN THE SECOND QUARTER OF 2026 WEAKER THAN EXPECTED

  • DEVYSER Q2 SALES SEK 60.2 MILLION

  • SALES HIT BY INVENTORY BUILD-UP AT CO'S LARGEST DISTRIBUTOR DURING 2025 AND START OF 2026

  • SEES SALES TO DISTRIBUTOR TO CONTINUE AT A SOFTER GROWTH RATE FOR THE REMAINDER OF THE CURRENT YEAR AND NORMALIZE FROM 2027 ONWARDS

  • GROUP’S LIQUIDITY AND CASH FLOW FORECAST REMAIN SATISFACTORY


Source text: ID:nMFN1J7Y9t

Further company coverage: DVYSR.ST


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Devyser Diagnostics AB

See all news